GSKs
- Health
US pulls GSK’s COVID drug as omicron sibling dominates cases
U.S. regulators say GlaxoSmithKline’s COVID-19 antibody drug should no longer be used because it is likely ineffective against the latest…
Read More » - Business
Unilever eyes GSK’s consumer goods arm in possible 50 bln-pound deal
Breadcrumb Trail Links PMN Economy PMN Business Author of the article: Reuters Siddharth Cavale and Ludwig Burger and Mrinmay Dey…
Read More »
